Divigel

Bioidentical Hormones vs. Standard HRT Standard HRT These are FDA-approved hormone medications that may contain: Synthetic hormones (like medroxyprogesterone acetate) Animal-derived hormones (like Premarin, made from pregnant mare urine) Chemically modified versions that work in your body similarly to natural hormones Bioidentical Hormones These have a molecular structure identical to hormones your body produces naturally. Many FDA-approved options exist, including: Estradiol patches (Vivelle-Dot, Climara) Estradiol gels (Divigel, Estrogel) Progesterone capsules (Prometrium - made from yams) The "Compounded" Distinction Some bioidentical hormones are custom-compounded by specialty pharmacies (like Women's International Pharmacy or Belmar Pharmacy), mixed to individual specifications - but these are not FDA-approved and have less quality oversight. Key Takeaway FDA-approved bioidentical options offer a good middle ground - natural molecular structure with regulatory oversight The marketing term "bioidentical" is sometimes overstated - what matters most is the type, dose, and delivery method Consult a menopause specialist (look for NAMS-certified practitioners) for personalized guidance.

Mentioned in position 4 of 8

Short answer: for most people who need systemic estrogen, the transdermal route (patch or gel) is generally safer than oral estrogen—especially with regard to blood clots (venous thromboembolism) and some liver/metabolic effects. Why: Oral estrogens go through the liver first (“first‑pass”), which raises clotting factors, increasing VTE risk (and can raise triglycerides and affect CRP). Multiple studies and meta‑analyses show oral menopausal estrogen is associated with a higher VTE risk than transdermal. Transdermal estradiol (patch or gel) delivers hormone directly into the bloodstream, avoids the first‑pass hepatic effect, gives steadier blood levels, and is not associated with the same increase in VTE risk in observational studies. Oral estrogen may also increase gallbladder disease more than transdermal. Both routes carry other risks that depend on dose, whether a progestin is also used (required if you have a uterus), age, time since menopause, and personal risk factors (smoking, obesity, prior clots, thrombophilia, stroke, active cancer). Practical choices (brand examples): Transdermal patches: Climara, Vivelle‑Dot (Evra in some countries), Alora, Minivelle — commonly used for lower VTE risk and steady estradiol levels. Transdermal gels/solutions: EstroGel, Divigel — alternatives if you don’t like patches. Oral tablets: Estrace (micronized estradiol) or Premarin (conjugated equine estrogens) — used widely but have higher hepatic effects than transdermal. Other important points: If you have a history of VTE, known thrombophilia (e.g., factor V Leiden), recent stroke, or active liver disease, systemic estrogen may be contraindicated — and transdermal is usually preferred over oral only after specialist input. If you have a uterus, you’ll usually need a progestogen as well to prevent endometrial hyperplasia. Micronized progesterone (Prometrium) is often used and may have a different side‑effect profile than some synthetic progestins. Use the lowest effective dose for the shortest time needed and review periodically. Avoid unregulated “compounded bioidentical” products unless closely supervised (they’re not FDA‑standardized). Next step: discuss your personal medical history (age, smoking, clot history, cardiovascular risk, family history of thrombosis or breast cancer, whether you still have your uterus) with your clinician to choose route, dose, and whether you need progestogen. I can help you list questions to bring to your provider or summarize risks based on specific personal factors if you want.

Mentioned in position 7 of 10

Bioidentical Hormones vs. Standard HRT Standard HRT These are FDA-approved hormone therapies that may include: Synthetic hormones (like medroxyprogesterone acetate) or animal-derived hormones Brands like Premarin (conjugated equine estrogens), Provera, or Prempro Standardized, tested doses with well-documented safety data Bioidentical Hormones These have a molecular structure identical to hormones your body produces naturally Two main types: FDA-approved bioidenticals - brands like Estrace, Prometrium, Vivelle-Dot, Divigel - these are well-tested and regulated Compounded bioidenticals - custom-mixed by compounding pharmacies, often prescribed by integrative medicine doctors - less regulated and less evidence-based Key Considerations Factor Standard HRT Bioidentical Regulation Strong FDA oversight Varies widely Evidence Extensive studies More limited Customization Standardized Can be tailored Cost Often insurance-covered Often out-of-pocket My Recommendation Start with FDA-approved bioidenticals like Prometrium or Vivelle-Dot - you get the "natural" molecular structure with regulatory safety backing. Always consult a gynecologist or endocrinologist before deciding.

Mentioned in position 7 of 7

Short answer If you want the safest, best‑studied option, ask first about evidence‑based (traditional) HRT using FDA‑approved products (estradiol ± a progestogen when you still have a uterus). BHRT (compounded “bioidentical” hormones) can be considered if you need a dose or formulation that’s not commercially available or you’ve had problems with standard products — but it’s less regulated and not proven safer or more effective. Why (brief) Traditional HRT: FDA‑approved products (brands and formulations) have known dosing, quality control, and safety data. Examples: estradiol patches (Vivelle‑Dot, Climara), estradiol gels (Divigel, EstroGel), oral estradiol (Estrace), vaginal estrogens (Vagifem, Estring). For progestogen: micronized progesterone (Prometrium) is a bioidentical, FDA‑approved option used to protect the uterus. BHRT / compounded hormones: marketed as “natural” and individualized; may be useful for unusual dosing or preparations. But compounded products are not FDA‑reviewed for consistency or purity, variable between pharmacies, and major menopause societies do not recommend them as first‑line for routine use. Which to ask your clinician for Start by discussing goals and risks with a clinician experienced in menopause. If you have no major contraindications and want symptom control, ask about: Transdermal estradiol (patch or gel) if you want stable blood levels and lower VTE risk (brands above). Add micronized progesterone (Prometrium) if you still have a uterus. Vaginal estrogen (Vagifem, Estring) for local genitourinary symptoms if systemic therapy isn’t needed. Consider BHRT only after discussing pros/cons and only via a prescriber who knows menopause care and uses an accredited compounding pharmacy. Where to go / who to ask Look for a NAMS‑certified menopause practitioner (North American Menopause Society) — they specialize in up‑to‑date HRT management. Good places to get thorough evaluation: academic menopause clinics (Mayo Clinic Menopause Clinic, Cleveland Clinic Women’s Health, Johns Hopkins Menopause Program) or a board‑certified gynecologist/endocrinologist with menopause experience. If you pursue compounded BHRT, use a reputable, accredited compounding pharmacy (look for PCAB/ACHC accreditation and certificates of analysis). Well‑known compounding pharmacies used by many clinicians include Wedgewood Pharmacy, Belmar Pharmacy, and Empower Pharmacy — but verify accreditation and quality documentation yourself. Practical points to discuss with the clinician Your symptoms, age, time since menopause, personal/family history of breast cancer, blood clots, heart disease, stroke. Whether you still have a uterus (determines need for progestogen). Route preference (patch/gel/oral/vaginal) — transdermal is often preferred if clot risk is a concern. Safety, duration, monitoring plan, and non‑hormonal alternatives (SSRIs/SNRIs, gabapentin, topical vaginal estrogen). If considering BHRT, insist on lab test validity (avoid saliva tests as sole basis), pharmacy accreditation, and a clear plan for follow‑up. If you’d like, tell me: your age, how long since menopause or last period, main symptoms, and any major health history (clotting, breast cancer, heart disease). I can suggest questions to bring to a clinician and which specific formulations are most likely to fit your situation.

Mentioned in position 3 of 11

BHRT vs Traditional HRT: What to Ask For Quick Distinction Traditional HRT: Standardized FDA-approved doses (Premarin, Estrace, Vivelle-Dot, etc.) BHRT: Hormones chemically identical to your body's own hormones, either FDA-approved or custom-compounded Honest Assessment FDA-approved BHRT options are often the best starting point - they give you the benefits of bioidentical hormones with proven safety data. Recommended FDA-Approved BHRT Products Estradiol: Vivelle-Dot patch, Estrace, Divigel Progesterone: Prometrium (oral capsule) Testosterone: Intrarosa, though often prescribed off-label Compounded BHRT (more controversial) Wiley Protocol, custom pellets - less regulated, inconsistent dosing Use cautiously and only through reputable compounding pharmacies Where to Go Midi Health (telehealth, menopause specialists) - highly recommended Alloy (telehealth, affordable) Gennev (menopause-focused) NAMS-certified menopause practitioners at nams.org/find-a-provider Bottom Line Ask for FDA-approved bioidentical options first. Be skeptical of expensive compounded pellets with big marketing claims. Want specifics about any particular symptoms?

Mentioned in position 3 of 9

Short answer: For most people who need systemic estrogen, transdermal estrogen (patch/gel) is generally safer than oral estrogen for blood-clot and some cardiovascular risks. But the best choice depends on your health history, symptoms, and preferences — discuss with your clinician. Why transdermal (patch/gel) is often safer Bypasses first-pass liver metabolism, so it has less effect on liver-made clotting factors, CRP and triglycerides. That is why transdermal estradiol is associated with a lower risk of venous thromboembolism (VTE) and probably a lower stroke risk than oral estrogens in most observational studies. Good option if you have VTE risk factors (history of VTE, obesity, age, smoking, genetic thrombophilia), or if you have high triglycerides or certain liver issues. Why oral estrogen can carry higher risk Oral estrogens (conjugated estrogens or oral estradiol) go through the liver first, raising clotting factors, sex‑hormone binding globulin (SHBG), CRP and triglycerides, which is linked to a higher VTE risk and possibly higher stroke risk compared with transdermal. Oral pills are convenient and often less expensive, and some women tolerate them better. Other safety and practical points If you still have a uterus, estrogen must be combined with a progestogen to prevent endometrial hyperplasia/cancer. Progestogen can be given orally (micronized progesterone) or via a levonorgestrel IUD (Mirena), which is often preferred for targeted progestin delivery. Local low‑dose vaginal estrogen (cream, ring, tablet) is safest for isolated vaginal symptoms and has minimal systemic exposure. Side effects: patches/gel can cause local skin irritation or adhesion problems; pills can cause nausea or liver-related effects. Absolute contraindications to systemic estrogen include active or recent VTE, untreated estrogen-sensitive cancer, active liver disease, and some forms of cardiovascular disease — so individual risk assessment is essential. Brand examples (to discuss with your clinician) Transdermal patches: Vivelle‑Dot (estradiol patch), Climara (estradiol patch), Alora — commonly used, steady delivery, lower systemic clot risk. Transdermal gel: EstroGel, Divigel — alternative if you prefer not to use patches. Oral pills: Estrace (micronized 17β‑estradiol) and Premarin (conjugated equine estrogens) — familiar oral options; be aware of higher first‑pass effects. Progestogen options: Prometrium (micronized progesterone oral) or Mirena (levonorgestrel IUD) for endometrial protection. What to do next Talk with your clinician about your age, time since menopause, personal and family history (VTE, stroke, heart disease, breast cancer), smoking and BMI. If clot risk is a concern, transdermal formulations are usually preferred. If you want, tell me a bit about your health history and symptoms and I can summarize the pros/cons specific to you.

Mentioned in position 5 of 9